Development of a nasal cast model to test medicinal nasal devices.
Bespak, a division of Consort Medical plc, and Queen's University Belfast have developed a viable and unique in-vitro testing capability for nasal drug delivery devices. The aim was to evaluate and optimize current and conceptual drug delivery devices by quantifying the deposition of drug in the various distinct regions of the nasal cavity. The development of this test apparatus employed computed tomography (CT) scan data of the human nasal cavity to construct an accurate representation of the human nasal airways. An investigation of suitable materials and manufacturing technologies was required, together with extensive analytical method development. It is possible for this technique to be further developed in an attempt to create a standardized apparatus based on nasal geometry that can be used to compare accurately deposition from drug delivery devices. This paper presents the issues encountered in the development of this test apparatus, including manufacturing and material limitations, investigation and choice of suitable materials, laboratory testing considerations, and the steps required to validate the analytical process.
Hughes
R
R
School of Mechanical and Aerospace Engineering, Queen's University, Ashby Building, Stranmillis Road, Belfast, BT9 5AH, UK. ramyh79@hotmail.com
Watterson
J
J
Dickens
C
C
Ward
D
D
Banaszek
A
A
D000281:Administration, Intranasal; D000336:Aerosols / Q000008:administration & dosage*; D019544:Equipment Failure Analysis / Q000295:instrumentation* / Q000379:methods; D006801:Humans; D008953:Models, Anatomic; D009296:Nasal Cavity / Q000033:anatomy & histology* / Q000502:physiology*; D009330:Nebulizers and Vaporizers
D000336:Aerosols